Ankyra
PrivateLast Round
Series B
Nov 12, 2021
Total Funding Raised
$50M
Momentum Score
25 /100
Company Overview
Ankyra is a biotechnology company specializing in innovative cancer therapy services that enhance the safety and effectiveness of cytokine immunotherapies for patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ankyra Comps
Public and private peers based on sector, stage, and business model.
Ankyra Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 12, 2021 | ||||
| Series A | May 4, 2020 |
Key People
Founding team and executive leadership
Ankyra Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GV | Series B |
| Fidelity Management & Research Company | Series B |
| Borealis Ventures | Series B |
| Polaris Partners | Series B, Series A |
| Sands Capital | Series B |
| Spring Mountain Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Clinical presentations on novel IL-12 immunotherapy at AACR 2026.
- Apr 16, 2026
Will present at the AACR 2026 conference.
Ankyra Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ankyra's valuation, stock price, and market status.
